Synthesis of some new homodrimane sesquiterpenoids with 1,3,4-oxadiazole fragment
Închide
Articolul precedent
Articolul urmator
322 2
Ultima descărcare din IBN:
2021-04-07 09:08
SM ISO690:2012
ARICU, Aculina; KUCHKOVA, Kaleria; SECARA, Elena; BARBA, Alic; DRAGALIN, Ion; UNGUR, Nicon. Synthesis of some new homodrimane sesquiterpenoids with 1,3,4-oxadiazole fragment. In: Achievements and perspectives of modern chemistry. 9-11 octombrie 2019, Chişinău. Chisinau, Republic of Moldova: Tipografia Academiei de Ştiinţe a Moldovei, 2019, p. 239. ISBN 978-9975-62-428-2.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Achievements and perspectives of modern chemistry 2019
Conferința "International Conference "Achievements and perspectives of modern chemistry""
Chişinău, Moldova, 9-11 octombrie 2019

Synthesis of some new homodrimane sesquiterpenoids with 1,3,4-oxadiazole fragment


Pag. 239-239

Aricu Aculina, Kuchkova Kaleria, Secara Elena, Barba Alic, Dragalin Ion, Ungur Nicon
 
Institute of Chemistry
 
Disponibil în IBN: 12 noiembrie 2019


Rezumat

For the purpose searching of new biologically active compounds, herein, we describe the obtaining of 5-(delta8,9-bicyclohomofarnesenyl)-1,3,4-oxadiazol-2(3H)-thione (5), 2-allylamino-5-(delta8,9-bicyclohomofarnesenyl)-1,3,4-oxadiazole (7a), and 2-phenylamino-5-(delta8,9bicyclohomofarnesenyl)-1,3,4-oxadiazole (7b) from commercially available norambreinolide (1), according the scheme.formulaReagents and conditions: a) (COCl)2, C6H6, 20°C, 1 h, delta, 1 h; b) N2H4•H2O (98%), CH2Cl2, 20°C, 2 h, delta, 6 h, 65%; c) TMTD, DMF, 90°C, 1.5 h, 70%; d) R-NCS, EtOH, 20°C, 4 h, 8090%; e) DCC, CH3OH – CH3COCH3 (1:1), delta, 5 h, 56-76%. The structures of the newly obtained compounds were proved by IR-, 1H- and 13C NMRspectroscopy and mass-spectra.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-87421</cfResPublId>
<cfResPublDate>2019</cfResPublDate>
<cfStartPage>239</cfStartPage>
<cfISBN>978-9975-62-428-2</cfISBN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/87421</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'><p>Synthesis of some new homodrimane sesquiterpenoids with 1,3,4-oxadiazole fragment</p></cfTitle>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>For the purpose searching of new biologically active compounds, herein, we describe the obtaining of 5-(delta8,9-bicyclohomofarnesenyl)-1,3,4-oxadiazol-2(3H)-thione (5), 2-allylamino-5-(delta8,9-bicyclohomofarnesenyl)-1,3,4-oxadiazole (7a), and 2-phenylamino-5-(delta8,9bicyclohomofarnesenyl)-1,3,4-oxadiazole (7b) from commercially available norambreinolide (1), according the scheme.</p><p>formula</p><p>Reagents and conditions: a) (COCl)2, C6H6, 20&deg;C, 1 h, delta, 1 h; b) N2H4&bull;H2O (98%), CH2Cl2, 20&deg;C, 2 h, delta, 6 h, 65%; c) TMTD, DMF, 90&deg;C, 1.5 h, 70%; d) R-NCS, EtOH, 20&deg;C, 4 h, 8090%; e) DCC, CH3OH &ndash; CH3COCH3 (1:1), delta, 5 h, 56-76%. The structures of the newly obtained compounds were proved by IR-, 1H- and 13C NMRspectroscopy and mass-spectra.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-11130</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11165</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-26924</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11134</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-568</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-672</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-11130</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11130-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
<cfFamilyNames>Aricu</cfFamilyNames>
<cfFirstNames>Aculina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11165</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11165-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
<cfFamilyNames>Kuchkova</cfFamilyNames>
<cfFirstNames>Kaleria</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-26924</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-26924-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
<cfFamilyNames>Secara</cfFamilyNames>
<cfFirstNames>Elena</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11134</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11134-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
<cfFamilyNames>Barba</cfFamilyNames>
<cfFirstNames>Alic</cfFirstNames>
<cfFamilyNames>Барба</cfFamilyNames>
<cfFirstNames>Алик</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-568</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-568-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
<cfFamilyNames>Драгалин</cfFamilyNames>
<cfFirstNames>Ион</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-672</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-672-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2019T24:00:00</cfStartDate>
<cfFamilyNames>Унгур</cfFamilyNames>
<cfFirstNames>Никон</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>